/
Pipeline Programs↗
Active Trials↗
Companies Involved↗
HPV Positive Oropharyngeal Squamous Cell Carcinoma is an early-stage landscape with 5 programs across 4 companies. The most active players are Nykode Therapeutics ASA.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Bubble size = clinical trials
Key Players
Pipeline
Analysis
67%
Small molecule
2 of 3 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 3 classified programs, each share of the total. Modality classified for 80% of 5 pipeline programs.
Analysis
6
clinical trials
Clinical Trials
6 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)